Anna Lucia Fallacara

744 citations

28 papers · 603 indexed · h-index 17

Co-authors: Maurizio Botta Silvia Schenone Cristina Tintori Francesca Musumeci Claudio Zamperini Chiara Brullo Elena Dreassi Adriano Angelucci
Topics: Quinazolinone synthesis and applications (6 papers)Click Chemistry and Applications (5 papers)Neuroblastoma Research and Treatments (5 papers)
Cited by: Genetics Organic Chemistry Molecular Biology
Journals: International Journal of Molecular Sciences Journal of Medicinal Chemistry Molecules
Partner nations: Italy United States Türkiye

In The Last Decade

Anna Lucia Fallacara

28 papers receiving 597 citations

Peers

Countries citing papers authored by Anna Lucia Fallacara

Since Specialization

Citations

This map shows the geographic impact of Anna Lucia Fallacara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lucia Fallacara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lucia Fallacara more than expected).

Fields of papers citing papers by Anna Lucia Fallacara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lucia Fallacara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lucia Fallacara. The network helps show where Anna Lucia Fallacara may publish in the future.

Co-authorship network of co-authors of Anna Lucia Fallacara

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lucia Fallacara. A scholar is included among the top collaborators of Anna Lucia Fallacara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lucia Fallacara. Anna Lucia Fallacara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma 2022 ·Biomedicines ·(unknown),Fabio Pastorino,Chiara Brignole,Arianna Mancini,(unknown),(unknown),Claudio Zamperini,(unknown),Anna Lucia Fallacara,(unknown),(unknown),Massimo Valoti,Silvia Schenone,Adriano Angelucci,Mirco Ponzoni,Elena Dreassi,Maurizio Botta	8
2	Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma 2021 ·European Journal of Medicinal Chemistry ·(unknown),Lucia D’Antona,(unknown),Annalaura Brai,Arianna Mancini,Claudio Zamperini,(unknown),(unknown),Anna Lucia Fallacara,(unknown),(unknown),Silvia Schenone,Nicola Perrotti,Elena Dreassi,Maurizio Botta	10
3	A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 2019 ·Cancers ·Anna Lucia Fallacara,Claudio Zamperini,Ana Podolski-Renić,Jelena Dinić,Tijana Stanković,(unknown),Arianna Mancini,(unknown),(unknown),(unknown),Francesca Bugli,Maurizio Sanguinetti,Riccardo Torelli,Maurizio Martini,Laura Maccari,Massimo Valoti,Elena Dreassi,Maurizio Botta,Milica Pešić,Silvia Schenone	39
4	Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines 2019 ·European Journal of Medicinal Chemistry ·Anna Lucia Fallacara,(unknown),Mattia Mori,(unknown),Francesca Musumeci,(unknown),Emmanuele Crespan,(unknown),Giovanni Maga,Chiara Tarantelli,Filippo Spriano,Eugenio Gaudio,Francesco Bertoni,Maurizio Botta,Silvia Schenone	14
5	Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Anna Lucia Fallacara,(unknown),Claudio Zamperini,(unknown),Francesca Musumeci,Silvia Schenone,Adriano Angelucci,Alessandro Colapietro,Emmanuele Crespan,(unknown),Giovanni Maga,Maurizio Botta	22
6	Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction 2018 ·European Journal of Medicinal Chemistry ·Ilaria D’Agostino,(unknown),Giulio Nannetti,Anna Lucia Fallacara,Davide Deodato,Francesca Musumeci,Giancarlo Grossi,Giorgio Palù,Ylenia Cau,(unknown),Arianna Loregian,Silvia Schenone,Maurizio Botta	26
7	An Update on JAK Inhibitors 2018 ·Current Medicinal Chemistry ·Francesca Musumeci,(unknown),(unknown),Anna Lucia Fallacara,Munjed M. Ibrahim,Giancarlo Grossi,Chiara Brullo,Silvia Schenone	25
8	Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model 2017 ·Journal of Medicinal Chemistry ·Gianluca Vignaroli,(unknown),Claudio Zamperini,(unknown),(unknown),(unknown),Anna Lucia Fallacara,(unknown),(unknown),David Colecchia,A. Mancini,Claudio Festuccia,Elena Dreassi,Massimo Valoti,Francesca Musumeci,M Chiariello,Adriano Angelucci,Maurizio Botta,Silvia Schenone	31
9	Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line 2017 ·Bioorganic & Medicinal Chemistry Letters ·Anna Lucia Fallacara,Arianna Mancini,Claudio Zamperini,Elena Dreassi,(unknown),M Chiariello,Gianni Pozzi,Francesco Santoro,(unknown),Silvia Schenone	23
10	Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors 2017 ·Expert Opinion on Therapeutic Patents ·Francesca Musumeci,(unknown),(unknown),(unknown),Anna Lucia Fallacara,Rosario Amato,Silvia Schenone	10
11	A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutant 2016 ·Bioorganic & Medicinal Chemistry Letters ·Marco Radi,R. Schneider,Anna Lucia Fallacara,Lorenzo Botta,Emmanuele Crespan,Cristina Tintori,Giovanni Maga,(unknown),(unknown),André Richters,Francesca Musumeci,Daniel Rauh,Silvia Schenone	2
12	Identification of new pyrrolo[2,3- d ]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma 2016 ·European Journal of Medicinal Chemistry ·Francesca Musumeci,Anna Lucia Fallacara,Chiara Brullo,Giancarlo Grossi,Lorenzo Botta,(unknown),M Chiariello,(unknown),Emmanuele Crespan,Giovanni Maga,Silvia Schenone	28
13	4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA–PB1 Protein–Protein Interaction: Structure–Activity Relationships Exploration with the Aid of Molecular Modeling 2016 ·Journal of Medicinal Chemistry ·(unknown),Giulio Nannetti,Cristina Tintori,Anna Lucia Fallacara,Davide Deodato,Beatrice Mercorelli,Giorgio Palù,Maikel Wijtmans,(unknown),Ewald Edink,Mark H.P. Verheij,Iwan J. P. de Esch,(unknown),Arianna Loregian,Maurizio Botta	51
14	3‐Arylidene‐N‐hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity 2016 ·ChemMedChem ·Loana Musso,Raffaella Cincinelli,Valentina Zuco,Michelandrea De Cesare,Franco Zunino,Anna Lucia Fallacara,Maurizio Botta,Sabrina Dallavalle	6
15	Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors 2015 ·ChemMedChem ·(unknown),Anna Lucia Fallacara,(unknown),Laura Mennuni,(unknown),Adriano Angelucci,Silvia Schenone,Maurizio Botta	15
16	Insight into the Allosteric Inhibition of Abl Kinase 2014 ·Journal of Chemical Information and Modeling ·Anna Lucia Fallacara,Cristina Tintori,Marco Radi,Silvia Schenone,Maurizio Botta	15
17	Protein–protein interactions and human cellular cofactors as new targets for HIV therapy 2014 ·Current Opinion in Pharmacology ·Cristina Tintori,Annalaura Brai,Anna Lucia Fallacara,(unknown),Silvia Schenone,Maurizio Botta	22
18	High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA–PB1 protein–protein interaction 2013 ·Bioorganic & Medicinal Chemistry Letters ·Cristina Tintori,Ilaria Laurenzana,Anna Lucia Fallacara,Ulrich Keßler,(unknown),Lilli Stergiou,Maurizio Botta	30
19	The Fight against the Influenza A Virus H1N1: Synthesis, Molecular Modeling, and Biological Evaluation of Benzofurazan Derivatives as Viral RNA Polymerase Inhibitors 2013 ·ChemMedChem ·(unknown),Daniele Castagnolo,(unknown),Anna Lucia Fallacara,Ilaria Laurenzana,Davide Deodato,Ulrich Keßler,(unknown),Lilli Stergiou,(unknown),Cristina Tintori,Maurizio Botta	32
20	Probing the Binding Site of Abl Tyrosine Kinase Using in Situ Click Chemistry 2013 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),(unknown),Gaia Fumagalli,Michael S. Christodoulou,Damiano Monticelli,(unknown),Anna Lucia Fallacara,Cristina Tintori,Maurizio Botta,Daniele Passarella	31

About Anna Lucia Fallacara

Anna Lucia Fallacara is a scholar working on Genetics, Organic Chemistry and Hematology, having authored 28 papers that have together received 603 indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (6 papers), Click Chemistry and Applications (5 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Genetics (87 citations), Organic Chemistry (230 citations) and Molecular Biology (299 citations). Anna Lucia Fallacara has collaborated with scholars based in Italy, United States and Türkiye. Frequent co-authors include Maurizio Botta, Silvia Schenone, Cristina Tintori, Francesca Musumeci, Claudio Zamperini, Chiara Brullo, Elena Dreassi, Adriano Angelucci, Giancarlo Grossi and Giovanni Maga. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact